<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00247039</url>
  </required_header>
  <id_info>
    <org_study_id>384 gar 1- HMO-CTIL</org_study_id>
    <secondary_id>GAR1</secondary_id>
    <nct_id>NCT00247039</nct_id>
  </id_info>
  <brief_title>Garlic in Patients With Febrile Neutropenia</brief_title>
  <official_title>A Controlled Study to Determine The Clinical Efficacy Of Garlic Compounds In Patients With Chemotherapy Related Febrile Neutropenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the clinical effects of garlic in preventing and treatment of patients with
      chemotherapy related febrile neutropenia.These patients have a very high incidence of
      infections which are not routinely covered by the standard empiric therapy. Adding a non-
      toxic and possibly effective therapy may reduce the risk for infections, synergize the
      empiric antibiotic treatment and may lessen the need for broader spectrum and more severe
      side effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients eligible are randomized to receive placebo or garlic capsules after chemotherapy
      course and until leukocyte recovery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to fever and beginning of empiric antibiotic treatment.</measure>
    <time_frame>0-45 days post chemotherapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Documented and culture positive infections.</measure>
    <time_frame>as above</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kind of infectious organisms and sensitivity to medicines.</measure>
    <time_frame>as above</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of infection</measure>
    <time_frame>as above</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of growth factors.</measure>
    <time_frame>as above</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chemotherapy</condition>
  <condition>Neutropenia</condition>
  <arm_group>
    <arm_group_label>Garlic extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Garlic extract capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Solgar Israel</intervention_name>
    <description>Dietary Supplement: garlic natural compound one pill, 450 mg active garlic extract (Solgar, Israel), bid.</description>
    <arm_group_label>Garlic extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo capsules</intervention_name>
    <description>placebo capsules</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        FN patients expected to have at least 5 days or more of neutropenia will be eligible for
        treatment with garlic compounds AST/ALT ≤ 3 times the upper limit of institutional
        laboratory normal.

        Total bilirubin ≤ 2 times the upper limit of institutional laboratory normal.

        BUN and creatinine should be ≤ 3 times the upper limit of institutional laboratory normal.

        Newly diagnosed as well as previously treated patients will be eligible.

        Exclusion Criteria:

        History of clinically significant liver or kidney disease.

        Patients on anti-coagulation therapy with Coumadin will be excluded because of the
        potential garlic interference with metabolism.

        Patients receiving concomitant chemotherapeutic treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>moshe e gatt, dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>moshe e gatt, dr</last_name>
    <phone>972-50-5172333</phone>
    <email>dr.mgatt@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>arik Tzukert, DMD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>moshe e gatt, dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2005</study_first_submitted>
  <study_first_submitted_qc>October 31, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2005</study_first_posted>
  <last_update_submitted>July 4, 2013</last_update_submitted>
  <last_update_submitted_qc>July 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Moshe Gatt</investigator_full_name>
    <investigator_title>Dr. Moshe Gatt</investigator_title>
  </responsible_party>
  <keyword>neutropenia</keyword>
  <keyword>fever</keyword>
  <keyword>garlic</keyword>
  <keyword>infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neutropenia</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

